Archive 1995–2023
2017, volume 33, issue 3-4
Editorial
Editorial
Janusz Rybakowski
Farmakoterapia w Psychiatrii i Neurologii 2017, 33 (3–4), 165–167
Original article
Five-year observation of chronic renal insufficiency during lithium treatment. A case study of four patients
Maria Abramowicz, Janusz K. Rybakowski, Agnieszka Permoda-Osip, Barbara Nowak, Paweł Olejniczak
Farmakoterapia w Psychiatrii i Neurologii 2017, 33 (3–4), 169–179
Original article
Uric acid concentration in bipolar disorder and schizophrenia
Magda Malewska, Agnieszka Permoda-Osip, Paweł Kasprzak, Aleksandra Niemiec, Janusz Rybakowski
Farmakoterapia w Psychiatrii i Neurologii 2017, 33 (3–4), 181–187
Original article
Adipokines and metabolic consequences of atypical antipsychotic drugs in children and adolescents
Marta Tyszkiewicz-Nwafor, Małgorzata Golec, Lidia Matuszak-Wojciechowska, Agnieszka Jarząbek-Cudo, Agnieszka Słopień, Filip Rybakowski
Farmakoterapia w Psychiatrii i Neurologii 2017, 33 (3–4), 189–202
Review article
Psilocybin: the possibility of therapeutic use in selected mental and neurological disorders
Karolina Dydak, Mariola Śliwińska-Mossoń, Marzenna Bartoszewicz, Halina Milnerowicz
Farmakoterapia w Psychiatrii i Neurologii 2017, 33 (3–4), 203–223
Review article
Adjuvant anti-inflammatory therapy in schizophrenia – current evidence
Filip Stramecki, Błażej Misiak, Dorota Frydecka
Farmakoterapia w Psychiatrii i Neurologii 2017, 33 (3–4), 225–238
Review article
Vortioxetine or duloxetine – patient’s profile and individualization of therapy based on case reports
Piotr Baranowski, Dorota Kuczborska-Majda
Farmakoterapia w Psychiatrii i Neurologii 2017, 33 (3–4), 239–250
Scientific conference report
Report of the 5 th ECNP School of Child and Adolescent Neuropsychopharmacology (Venice, Italy, 2–7 April 2017)
Anna Zielińska, Piotr Niwiński
Farmakoterapia w Psychiatrii i Neurologii 2017, 33 (3–4), 251–261